Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 620

1.

Twenty-four Hour Subjective and Pharmacological Effects of Ad Libitum Electronic and Combustible Cigarette Use among Dual Users.

Harvanko AM, St Helen G, Nardone N, Addo N, Benowitz NL.

Addiction. 2019 Dec 14. doi: 10.1111/add.14931. [Epub ahead of print]

PMID:
31837232
2.

Biomarkers of Exposure for Dual Use of Electronic Cigarettes and Combustible Cigarettes: Nicotelline, NNAL, and Total Nicotine Equivalents.

Jacob P, St Helen G, Yu L, Nardone N, Havel C, Cheung P, Benowitz NL.

Nicotine Tob Res. 2019 Dec 13. pii: ntz235. doi: 10.1093/ntr/ntz235. [Epub ahead of print]

PMID:
31833541
3.

Characterization of Nicotine Salts in 23 Electronic Cigarette Refill Liquids.

Harvanko AM, Havel CM, Jacob P, Benowitz NL.

Nicotine Tob Res. 2019 Dec 10. pii: ntz232. doi: 10.1093/ntr/ntz232. [Epub ahead of print]

PMID:
31821492
4.

The influence of nicotine metabolic rate on working memory over 6 hours of abstinence from nicotine.

Nardone N, Shahid M, Strasser AA, Dempsey DA, Benowitz NL.

Pharmacol Biochem Behav. 2019 Dec 5:172836. doi: 10.1016/j.pbb.2019.172836. [Epub ahead of print]

PMID:
31812759
5.

Effect of e-cigarette flavors on nicotine delivery and puffing topography: results from a randomized clinical trial of daily smokers.

Voos N, Smith D, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, O'Connor RJ, Goniewicz ML.

Psychopharmacology (Berl). 2019 Nov 26. doi: 10.1007/s00213-019-05386-x. [Epub ahead of print]

PMID:
31773209
6.

Effects of Nicotine Metabolic Rate on Cigarette Reinforcement.

Liakoni E, Nardone N, St Helen G, Dempsey DA, Tyndale RF, Benowitz NL.

Nicotine Tob Res. 2019 Nov 14. pii: ntz210. doi: 10.1093/ntr/ntz210. [Epub ahead of print]

PMID:
31725872
7.

Current advances in research in treatment and recovery: Nicotine addiction.

Prochaska JJ, Benowitz NL.

Sci Adv. 2019 Oct 16;5(10):eaay9763. doi: 10.1126/sciadv.aay9763. eCollection 2019 Oct. Review.

8.

Corrigendum to: Changes in Use Patterns Over 1 Year Among Smokers and Dual Users of Combustible and Electronic Cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 Oct 14. pii: ntz164. doi: 10.1093/ntr/ntz164. [Epub ahead of print] No abstract available.

PMID:
31609417
9.

Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.

Benowitz NL, Bernert JT, Foulds J, Hecht SS, Jacob P, Jarvis MJ, Joseph A, Oncken C, Piper ME.

Nicotine Tob Res. 2019 Oct 1. pii: ntz132. doi: 10.1093/ntr/ntz132. [Epub ahead of print]

PMID:
31570931
10.

E-Hookah Versus E-Cigarettes: Findings From Wave 2 of the PATH Study (2014-2015).

Rezk-Hanna M, Toyama J, Ikharo E, Brecht ML, Benowitz NL.

Am J Prev Med. 2019 Nov;57(5):e163-e173. doi: 10.1016/j.amepre.2019.05.007. Epub 2019 Sep 27.

PMID:
31564602
11.

Comparison of systemic exposure to toxic and/or carcinogenic volatile organic compounds (VOCs) during vaping, smoking, and abstention.

St Helen G, Liakoni E, Nardone N, Addo N, Jacob P, Benowitz NL.

Cancer Prev Res (Phila). 2019 Sep 25. pii: canprevres.0356.2019. doi: 10.1158/1940-6207.CAPR-19-0356. [Epub ahead of print]

PMID:
31554628
12.

Relationship between skin melanin index and nicotine pharmacokinetics in African American smokers.

Liakoni E, St Helen G, Dempsey DA, Jacob P 3rd, Tyndale RF, Benowitz NL.

Drug Alcohol Depend. 2019 Nov 1;204:107474. doi: 10.1016/j.drugalcdep.2019.04.039. Epub 2019 Aug 30.

PMID:
31521954
13.

E-cigarettes and dual nicotine replacement therapy for smoking cessation.

Benowitz NL.

Lancet Respir Med. 2019 Sep 9. pii: S2213-2600(19)30308-X. doi: 10.1016/S2213-2600(19)30308-X. [Epub ahead of print] No abstract available.

PMID:
31515174
14.

Exposure to a Tobacco-Specific Carcinogen Among Adolescent Smokeless Tobacco Users in Rural California, United States.

Chaffee BW, Jacob P, Couch ET, Benowitz NL.

Nicotine Tob Res. 2019 Aug 23. pii: ntz147. doi: 10.1093/ntr/ntz147. [Epub ahead of print]

PMID:
31504879
15.

Impact of early nausea on varenicline adherence and smoking cessation.

Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF.

Addiction. 2019 Sep 10. doi: 10.1111/add.14810. [Epub ahead of print]

PMID:
31502736
16.

Biomarkers of Exposure to Nicotine and Tobacco-specific Nitrosamines in Adolescent Blunt Users.

Nardone N, Jain S, Benowitz NL.

Nicotine Tob Res. 2019 Aug 21. pii: ntz144. doi: 10.1093/ntr/ntz144. [Epub ahead of print] No abstract available.

PMID:
31433049
17.

JUUL electronic cigarettes: Nicotine exposure and the user experience.

Nardone N, Helen GS, Addo N, Meighan S, Benowitz NL.

Drug Alcohol Depend. 2019 Oct 1;203:83-87. doi: 10.1016/j.drugalcdep.2019.05.019. Epub 2019 Aug 5.

PMID:
31408770
18.

Differences in exposure to toxic and/or carcinogenic volatile organic compounds between Black and White cigarette smokers.

St Helen G, Benowitz NL, Ko J, Jacob P, Gregorich SE, Pérez-Stable EJ, Murphy SE, Hecht SS, Hatsukami DK, Donny EC.

J Expo Sci Environ Epidemiol. 2019 Aug 12. doi: 10.1038/s41370-019-0159-9. [Epub ahead of print]

PMID:
31406274
19.

Cytisine for nicotine addiction treatment: a review of pharmacology, therapeutics and an update of clinical trial evidence for smoking cessation.

Tutka P, Vinnikov D, Courtney RJ, Benowitz NL.

Addiction. 2019 Nov;114(11):1951-1969. doi: 10.1111/add.14721. Epub 2019 Jul 19.

PMID:
31240783
20.

Effects of immediate versus gradual nicotine reduction in cigarettes on biomarkers of biological effects.

Hatsukami DK, Luo X, Heskin AK, Tang MK, Carmella SG, Jensen J, Robinson JD, Vandrey R, Drobes DJ, Strasser AA, al'Absi M, Leischow S, Cinciripini PM, Koopmeiners J, Ikuemonisan J, Benowitz NL, Donny EC, Hecht SS.

Addiction. 2019 Oct;114(10):1824-1833. doi: 10.1111/add.14695. Epub 2019 Jul 8.

PMID:
31140663
21.

Black Light Smokers: How Nicotine Intake and Carcinogen Exposure Differ Across Various Biobehavioral Factors.

St Helen G, Benowitz NL, Ahluwalia JS, Tyndale RF, Addo N, Gregorich SE, Pérez-Stable EJ, Cox LS.

J Natl Med Assoc. 2019 May 10. pii: S0027-9684(19)30017-3. doi: 10.1016/j.jnma.2019.04.004. [Epub ahead of print]

PMID:
31084916
22.

Changes in Use Patterns OVER ONE YEAR Among Smokers and Dual Users of Combustible and electronic cigarettes.

Piper ME, Baker TB, Benowitz NL, Jorenby DE.

Nicotine Tob Res. 2019 May 6. pii: ntz065. doi: 10.1093/ntr/ntz065. [Epub ahead of print]

PMID:
31058284
23.

Longitudinal stability in cigarette smokers of urinary eicosanoid biomarkers of oxidative damage and inflammation.

Carmella SG, Heskin AK, Tang MK, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami DK, Hecht SS.

PLoS One. 2019 Apr 25;14(4):e0215853. doi: 10.1371/journal.pone.0215853. eCollection 2019.

24.

Stimulant drugs are associated with violent and penetrating trauma.

Armenian P, Effron Z, Garbi N, Dirks R, Benowitz NL, Gerona RR.

Am J Emerg Med. 2019 Apr;37(4):645-650. doi: 10.1016/j.ajem.2018.06.071. Epub 2018 Jul 3.

PMID:
30914133
25.

E-cigarette Dependence Measures in Dual Users: Reliability and Relations with Dependence Criteria and E-Cigarette Cessation.

Piper ME, Baker TB, Benowitz NL, Smith SS, Jorenby DE.

Nicotine Tob Res. 2019 Mar 15. pii: ntz040. doi: 10.1093/ntr/ntz040. [Epub ahead of print]

PMID:
30874804
26.

Urine Metabolites for Estimating Daily Intake of Nicotine from Cigarette Smoking.

Benowitz NL, Helen GS, Nardone N, Cox LS, Jacob P.

Nicotine Tob Res. 2019 Mar 10. pii: ntz034. doi: 10.1093/ntr/ntz034. [Epub ahead of print]

PMID:
30852610
27.

Randomized within-subject trial to evaluate smokers' initial perceptions, subjective effects and nicotine delivery across six vaporized nicotine products.

Voos N, Kaiser L, Mahoney MC, Bradizza CM, Kozlowski LT, Benowitz NL, O'Connor RJ, Goniewicz ML.

Addiction. 2019 Jul;114(7):1236-1248. doi: 10.1111/add.14602. Epub 2019 Apr 25.

PMID:
30851137
28.

Predictors of Neuropsychiatric Adverse Events with Smoking Cessation Medications in the Randomized Controlled EAGLES Trial.

Anthenelli RM, Gaffney M, Benowitz NL, West R, McRae T, Russ C, Lawrence D, St Aubin L, Krishen A, Evins AE.

J Gen Intern Med. 2019 Jun;34(6):862-870. doi: 10.1007/s11606-019-04858-2. Epub 2019 Mar 7.

PMID:
30847828
29.

Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity.

El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF.

Addict Biol. 2020 Jan;25(1):e12741. doi: 10.1111/adb.12741. Epub 2019 Feb 27.

PMID:
30815984
30.

Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial.

Evins AE, Benowitz NL, West R, Russ C, McRae T, Lawrence D, Krishen A, St Aubin L, Maravic MC, Anthenelli RM.

J Clin Psychopharmacol. 2019 Mar/Apr;39(2):108-116. doi: 10.1097/JCP.0000000000001015.

PMID:
30811371
31.

Loperamide associated torsades de pointes, in the setting of complete heart block at marginally supratherapeutic dosing (20mg/day).

Goodnough R, Nomura M, Badea A, Lynch KL, Benowitz NL, Tsutaoka B.

Clin Toxicol (Phila). 2019 Nov;57(11):1123-1124. doi: 10.1080/15563650.2019.1578369. Epub 2019 Feb 19. No abstract available.

PMID:
30777457
32.

High Carbon Monoxide Levels from Charcoal Combustion Mask Acute Endothelial Dysfunction Induced by Hookah (Waterpipe) Smoking in Young Adults.

Rezk-Hanna M, Mosenifar Z, Benowitz NL, Rader F, Rashid M, Davoren K, Moy NB, Doering L, Robbins W, Sarna L, Li N, Chang LC, Elashoff RM, Victor RG.

Circulation. 2019 May 7;139(19):2215-2224. doi: 10.1161/CIRCULATIONAHA.118.037375.

PMID:
30764644
33.

Managing Cannabis Use in Patients With Cardiovascular Disease.

Benowitz NL.

Can J Cardiol. 2019 Feb;35(2):138-141. doi: 10.1016/j.cjca.2018.12.033. Epub 2018 Dec 29. No abstract available.

PMID:
30760417
34.

Factors That Explain Differences in Abstinence Between Black and White Smokers: A Prospective Intervention Study.

Nollen NL, Mayo MS, Sanderson Cox L, Benowitz NL, Tyndale RF, Ellerbeck EF, Scheuermann TS, Ahluwalia JS.

J Natl Cancer Inst. 2019 Oct 1;111(10):1078-1087. doi: 10.1093/jnci/djz001.

PMID:
30657926
35.

Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial.

Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA.

JAMA Netw Open. 2018 Aug;1(4):e181346. doi: 10.1001/jamanetworkopen.2018.1346. Epub 2018 Aug 24.

36.

Identification and quantification of electronic cigarette exhaled aerosol residue chemicals in field sites.

Khachatoorian C, Jacob P 3rd, Sen A, Zhu Y, Benowitz NL, Talbot P.

Environ Res. 2019 Mar;170:351-358. doi: 10.1016/j.envres.2018.12.027. Epub 2018 Dec 16.

PMID:
30623881
37.

Evaluating the temporal relationships between withdrawal symptoms and smoking relapse.

Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM.

Psychol Addict Behav. 2019 Mar;33(2):105-116. doi: 10.1037/adb0000434. Epub 2019 Jan 7.

PMID:
30614717
38.

Longitudinal stability in cigarette smokers of urinary biomarkers of exposure to the toxicants acrylonitrile and acrolein.

Chen M, Carmella SG, Sipe C, Jensen J, Luo X, Le CT, Murphy SE, Benowitz NL, McClernon FJ, Vandrey R, Allen SS, Denlinger-Apte R, Cinciripini PM, Strasser AA, al'Absi M, Robinson JD, Donny EC, Hatsukami D, Hecht SS.

PLoS One. 2019 Jan 4;14(1):e0210104. doi: 10.1371/journal.pone.0210104. eCollection 2019.

39.

Reprint of: Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

Kalkhoran S, Benowitz NL, Rigotti NA.

J Am Coll Cardiol. 2018 Dec 11;72(23 Pt B):2964-2979. doi: 10.1016/j.jacc.2018.10.020. Review.

PMID:
30522631
40.

2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents.

Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS.

J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365. doi: 10.1016/j.jacc.2018.10.027. Epub 2018 Dec 5. Review. No abstract available.

PMID:
30527452
41.

Butanediol Conversion to Gamma-Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole.

Liakoni E, Gugelmann H, Dempsey DA, Wiegand TJ, Havel C, Jacob P, Benowitz NL.

Clin Pharmacol Ther. 2019 May;105(5):1196-1203. doi: 10.1002/cpt.1306. Epub 2019 Jan 8.

PMID:
30450642
42.

Biomarker feedback intervention for smoking cessation among Alaska Native pregnant women: Randomized pilot study.

Patten CA, Koller KR, Flanagan CA, Hiratsuka VY, Hughes CA, Wolfe AW, Decker PA, Fruth K, Brockman TA, Korpela M, Gamez D, Bronars C, Murphy NJ, Hatsukami D, Benowitz NL, Thomas TK.

Patient Educ Couns. 2019 Mar;102(3):528-535. doi: 10.1016/j.pec.2018.10.009. Epub 2018 Oct 12.

43.

Dual Users Compared to Smokers: Demographics, Dependence, and Biomarkers.

Piper ME, Baker TB, Benowitz NL, Kobinsky KH, Jorenby DE.

Nicotine Tob Res. 2019 Aug 19;21(9):1279-1284. doi: 10.1093/ntr/nty231.

PMID:
30365010
44.

Urine 4-(methylnitrosamino)-1-(3) pyridyl-1-butanol and cotinine in Alaska native postpartum women and neonates comparing smokers and smokeless tobacco users.

Benowitz NL, Flanagan CA, Thomas TK, Koller KR, Wolfe AW, Renner CC, Hughes C, Decker PA, Hatsukami DK, Murphy NJ, Patten C.

Int J Circumpolar Health. 2018 Dec;77(1):1528125. doi: 10.1080/22423982.2018.1528125.

45.

Effects of Nicotine Metabolic Rate on Withdrawal Symptoms and Response to Cigarette Smoking After Abstinence.

Liakoni E, Edwards KC, St Helen G, Nardone N, Dempsey DA, Tyndale RF, Benowitz NL.

Clin Pharmacol Ther. 2019 Mar;105(3):641-651. doi: 10.1002/cpt.1238. Epub 2018 Oct 25.

PMID:
30242831
46.

Effect of γ-hydroxybutyrate (GHB) on driving as measured by a driving simulator.

Liakoni E, Dempsey DA, Meyers M, Murphy NG, Fiorentino D, Havel C, Haller C, Benowitz NL.

Psychopharmacology (Berl). 2018 Nov;235(11):3223-3232. doi: 10.1007/s00213-018-5025-2. Epub 2018 Sep 19.

47.

Effect of Immediate vs Gradual Reduction in Nicotine Content of Cigarettes on Biomarkers of Smoke Exposure: A Randomized Clinical Trial.

Hatsukami DK, Luo X, Jensen JA, al'Absi M, Allen SS, Carmella SG, Chen M, Cinciripini PM, Denlinger-Apte R, Drobes DJ, Koopmeiners JS, Lane T, Le CT, Leischow S, Luo K, McClernon FJ, Murphy SE, Paiano V, Robinson JD, Severson H, Sipe C, Strasser AA, Strayer LG, Tang MK, Vandrey R, Hecht SS, Benowitz NL, Donny EC.

JAMA. 2018 Sep 4;320(9):880-891. doi: 10.1001/jama.2018.11473.

48.

Electronic cigarette chemicals transfer from a vape shop to a nearby business in a multiple-tenant retail building.

Khachatoorian C, Jacob Iii P, Benowitz NL, Talbot P.

Tob Control. 2019 Sep;28(5):519-525. doi: 10.1136/tobaccocontrol-2018-054316. Epub 2018 Aug 29.

PMID:
30158206
49.

IQOS: examination of Philip Morris International's claim of reduced exposure.

St Helen G, Jacob Iii P, Nardone N, Benowitz NL.

Tob Control. 2018 Nov;27(Suppl 1):s30-s36. doi: 10.1136/tobaccocontrol-2018-054321. Epub 2018 Aug 29.

50.

Prevention and Treatment of Tobacco Use: JACC Health Promotion Series.

Kalkhoran S, Benowitz NL, Rigotti NA.

J Am Coll Cardiol. 2018 Aug 28;72(9):1030-1045. doi: 10.1016/j.jacc.2018.06.036. Review.

Supplemental Content

Loading ...
Support Center